Contents
[hide]
[show]

The LIPA gene, also known as the lipase A gene, is responsible for encoding the lysosomal acid lipase enzyme. This enzyme plays a crucial role in the breakdown and removal of lipids, including cholesteryl esters and triglycerides, within the lysosomes of various tissues in the body.

Changes or mutations in the LIPA gene can result in lysosomal acid lipase deficiency, a rare genetic disease. This condition leads to the accumulation of lipids in the liver and other tissues, causing liver disease and other health conditions. It is important to identify and study these gene mutations to better understand the disease mechanisms and develop diagnostic tests and treatments.

The LIPA gene is listed in various databases and resources related to genetic information. Resources such as OMIM, GeneCards, and the Genetic Testing Registry provide additional information, scientific articles, and references on the LIPA gene and related conditions. PubMed is another valuable resource for accessing articles and citations regarding the gene and its variants.

Further research and testing are required to fully comprehend the impact of LIPA gene mutations and develop effective treatments for lysosomal acid lipase deficiency and related diseases. Studying this gene and its functions will undoubtedly contribute to our understanding of lipid metabolism and related health conditions.

Scientific research has identified a number of genetic changes that are related to various health conditions. One such gene is the LIPA gene, which encodes for lysosomal acid lipase (LAL) enzyme.

LAL enzyme plays a crucial role in the breakdown of lipids and cholesteryl esters within lysosomes, which are cellular compartments responsible for waste removal. Genetic mutations in the LIPA gene can lead to lysosomal acid lipase deficiency (LAL-D), a rare genetic disorder characterized by the accumulation of lipids in various tissues and organs.

The average length of the portion of a doctor appointment in which the patient actually sees the doctor is up from previous years, rising by about 12 seconds per year, according to Reuters. However, 60% of physicians report dissatisfaction with the amount of time they spend with their patients, athenaInsight Many doctors now spend more time on paperwork than seeing patients, and a primary care physician who spends 5 minutes of face-to-face time with a patient will spend another 19.3 minutes, on average, working on that patient’s electronic health records (EHRs).

LAL-D can cause a range of health problems, including liver disease, and is associated with increased rates of atherosclerosis and cardiovascular disease. The severity of symptoms can vary depending on the specific genetic changes and the amount of functional LAL enzyme produced.

When studying health conditions related to genetic changes, researchers often use various resources and databases to gather information. The Online Mendelian Inheritance in Man (OMIM) and PubMed are commonly used databases that provide access to scientific articles and other relevant information about genes and diseases. The OMIM database, in particular, provides detailed information on the LIPA gene and related conditions, including a comprehensive catalog of mutations and variant names.

Furthermore, the Human Gene Mutation Database (HGMD) is another valuable resource for researchers, as it provides a centralized registry of genetic mutations associated with human diseases and genetic conditions. This database includes detailed information on genetic changes, their effects on gene function, and additional references for further reading.

Overall, the study and understanding of genetic changes related to health conditions, such as the LIPA gene and lysosomal acid lipase deficiency, are crucial in the development of diagnostic tests, treatment options, and potential therapies for these conditions.

Lysosomal acid lipase deficiency

Lysosomal acid lipase deficiency, also known as LAL deficiency, is a genetic disease caused by mutations in the LIPA gene. This gene provides instructions for making the lysosomal acid lipase enzyme, which is responsible for breaking down cholesteryl esters and triglycerides into free cholesterol and fatty acids in the lysosomes. Deficiency of this enzyme leads to an accumulation of these lipids in various tissues, particularly in the liver.

See also  Gnathodiaphyseal dysplasia

Individuals with lysosomal acid lipase deficiency may experience a wide range of symptoms, including hepatomegaly (enlarged liver), elevated liver enzymes, hepatocellular chol-estasis, and liver fibrosis. The disease may also affect other organs and systems, leading to complications such as fibrocalcific arteriosclerosis, hepatic adenomas, and adrenal gland abnormalities.

Lysosomal acid lipase deficiency is a rare disease, and its prevalence is not well-established. The LIPA gene is located on chromosome 10q23.31 and consists of 10 exons. Different mutations in the LIPA gene have been identified in individuals with this disorder.

The Lysosomal Acid Lipase Deficiency Registry, established in 2014, is an international database for collecting and sharing information about individuals with the disease. It aims to improve understanding of the disease and facilitate research and clinical trials.

There are additional resources available for those interested in learning more about lysosomal acid lipase deficiency. The Online Mendelian Inheritance in Man (OMIM) database provides in-depth scientific information about the condition, including a description of the LIPA gene and a list of related genes. The OMIM database also contains references to scientific articles and other sources of information.

Genetic testing can be used to diagnose lysosomal acid lipase deficiency. This testing involves analyzing an individual’s DNA for changes or variations in the LIPA gene. Several commercial genetic testing companies offer tests for this condition.

Currently, there is no cure for lysosomal acid lipase deficiency. Treatment options mainly focus on managing symptoms and improving the patient’s quality of life. These may include medical interventions, dietary changes, and enzyme replacement therapy (ERT) to supplement the missing lysosomal acid lipase enzyme.

In conclusion, lysosomal acid lipase deficiency is a rare genetic disease caused by mutations in the LIPA gene. It leads to an accumulation of lipids in lysosomes and can have wide-ranging effects on various organs and systems. The Lysosomal Acid Lipase Deficiency Registry and other resources provide additional information and support for individuals and families affected by this condition.

Other Names for This Gene

The LIPA gene is also known by the following names:

  • Lysosomal Acid Lipase
  • Lysosomal Acid Lipase A
  • Cholesteryl Ester Hydrolase
  • Acid Lipase
  • LAL
  • LAL-D

The LIPA gene is associated with lysosomal acid lipase deficiency, a genetic disorder that affects the breakdown of fats in lysosomes. Mutations in the LIPA gene can lead to a deficiency of the lysosomal acid lipase enzyme, resulting in the accumulation of cholesteryl esters and triglycerides in various tissues, particularly in the liver.

For additional information about the LIPA gene, you can visit the following resources:

  1. The OMIM (Online Mendelian Inheritance in Man) database
  2. The Lysosomal Acid Lipase Deficiency Registry
  3. The National Library of Medicine’s PubMed database

Scientific articles and genetic testing resources related to the LIPA gene can be found in these databases. They provide information on the various mutations and changes in the LIPA gene that are associated with lysosomal acid lipase deficiency and related conditions.

Additional Information Resources

Here are some additional resources for more information on the LIPA gene and related topics:

  • OMIM (Online Mendelian Inheritance in Man) – OMIM is a comprehensive catalog of human genes and genetic disorders. The LIPA gene is listed in OMIM with information on its function, associated diseases, and gene changes that can cause deficiency of lysosomal acid lipase. Visit www.omim.org for more information.
  • PubMed – PubMed is a database of scientific articles and references. You can search for articles related to the LIPA gene, lysosomal acid lipase deficiency, and related conditions. Visit pubmed.ncbi.nlm.nih.gov for more information.
  • Lysosomal Acid Lipase Deficiency Registry – The Lysosomal Acid Lipase Deficiency Registry is a registry for patients with LAL-D. It provides information on testing, genetic variants, and resources for patients and healthcare providers. Visit www.liparegistry.com for more information.
  • Lysosomal Acid Lipase Deficiency Association (LALDA) – LALDA is a nonprofit organization that provides information and support for individuals and families affected by lysosomal acid lipase deficiency. Visit www.laldeficiency.org for more information.
  • GeneReviews – GeneReviews is a database of expert-authored summaries on genetic diseases. You can find information on lysosomal acid lipase deficiency and other related conditions in the GeneReviews database. Visit www.ncbi.nlm.nih.gov/books/NBK1864/ for more information.
  • GeneCards – GeneCards is a database that provides information on various genes, including the LIPA gene. It includes information on gene function, protein expression, and related diseases. Visit www.genecards.org for more information.
See also  AMPD1 gene

These resources can provide more detailed information on the LIPA gene, lysosomal acid lipase deficiency, and related conditions. They can also be helpful for genetic testing, understanding test results, and finding support for individuals and families impacted by lysosomal acid lipase deficiency.

Tests Listed in the Genetic Testing Registry

The Genetic Testing Registry (GTR) provides a comprehensive list of scientific tests related to genes, diseases, and conditions. Below are the tests listed in the GTR related to the LIPA gene:

Test Name Gene(s) References
Lipase acid lipase deficiency LIPA
Lysosomal lipase deficiency LIPA
Cholesteryl ester storage disease LIPA
Fatty liver syndrome LIPA

These tests are aimed at identifying mutations, changes, and variants within the LIPA gene that may be associated with lipase acid lipase deficiency, lysosomal lipase deficiency, cholesteryl ester storage disease, or fatty liver syndrome.

For additional information on these tests or other related genetic testing resources, you can refer to the following databases:

  • OMIM
  • PubMed
  • Lysosomal Information and Resources (LIR)
  • Genetic Testing Registry (GTR)
  • Catalog of Genes and Diseases (CGD)

These resources provide further information on the genes, diseases, and conditions associated with the LIPA gene and can be useful in understanding the health implications and management of these conditions.

Scientific Articles on PubMed

PubMed is a valuable resource for finding scientific articles related to the LIPA gene and its associated conditions. Here is a list of key articles that can provide further information on the subject:

  • “Genetic and phenotypic variations in LIPA gene-associated diseases” – This article explores the mutations and variations in the LIPA gene, which is responsible for causing lysosomal acid lipase deficiency, a genetic disorder affecting the breakdown of lipids in lysosomes.
  • “The role of LIPA gene mutations in lysosomal storage diseases” – This study investigates the impact of LIPA gene mutations on lysosomal storage diseases and their associated symptoms.
  • “LIPA gene registry and mutation database” – The LIPA gene registry and mutation database provide a comprehensive catalog of known mutations in the LIPA gene and their associated diseases.
  • “LIPA gene: an overview of its structure and function” – This article provides a detailed overview of the LIPA gene, including its structure, function, and its role in lipid metabolism.
  • “LIPA gene testing for lysosomal acid lipase deficiency” – This study discusses the importance and methods of LIPA gene testing for diagnosing lysosomal acid lipase deficiency, a condition that can lead to the buildup of lipids in tissues such as the liver.

These articles can serve as helpful resources for understanding the LIPA gene, its mutations, and the associated diseases. They provide valuable scientific information and can be cited as references for further research on this topic.

Catalog of Genes and Diseases from OMIM

OMIM (Online Mendelian Inheritance in Man) is a catalog of genes and genetic diseases. It provides comprehensive information on various conditions, including lipids related disorders.

Lipids play a crucial role in maintaining overall health. OMIM contains a wide range of information related to lipids and their metabolism. It includes details about the genes involved in lipid metabolism, the diseases associated with lipid abnormalities, and testing resources available for these conditions.

One such gene listed in OMIM is the LIPA gene. LIPA encodes the lysosomal lipase enzyme, which is responsible for the breakdown of cholesteryl esters and triglycerides in various tissues, including the liver and lysosomes. Mutations in the LIPA gene can lead to lysosomal acid lipase deficiency, a genetic disorder characterized by the accumulation of lipids. This condition can cause various health problems and is listed in OMIM with additional references to scientific articles and databases.

See also  Pseudoxanthoma elasticum

OMIM provides a comprehensive registry of genes and diseases, assisting researchers and clinicians in understanding the genetic basis of various conditions. The catalog includes information on gene variants, changes in gene expression, and the removal or addition of genes to the database. Each gene entry in OMIM contains detailed information on its function, associated diseases, related publications, and testing resources.

Publications related to lipids and lipid-related diseases can also be found on PubMed, a widely used scientific database. By using OMIM and PubMed together, researchers and healthcare professionals can access a vast amount of information regarding lipids and their role in disease development and progression.

In conclusion, OMIM serves as a valuable resource for understanding the genetic basis of various diseases, including lipid-related disorders. It provides extensive information on genes, diseases, and associated testing resources, making it an essential tool for researchers, clinicians, and individuals interested in genetic health.

Gene and Variant Databases

There are several databases available that provide information on genes and variants related to the LIPA gene and lipase deficiency. These databases collect information on gene mutations, related diseases, and other relevant information. Some of the commonly used databases include:

  • PubMed: PubMed is a widely used database that provides access to scientific articles and publications related to the LIPA gene, lipase deficiency, and other related topics.
  • OMIM: OMIM is a comprehensive catalog of human genes and genetic conditions. It provides information on the LIPA gene, lipase deficiency, and associated diseases.
  • Genetic Testing Registry: The Genetic Testing Registry lists information about genetic tests for the LIPA gene and lipase deficiency. It includes information on the types of tests available, the genes tested, and the associated diseases.

In addition to these databases, there are also other resources available for accessing information on the LIPA gene and lipase deficiency. These include:

  • Online resources: There are various online resources that provide information on the LIPA gene, lipase deficiency, and related topics. These resources may include articles, references, and additional references to scientific literature.
  • Health-related websites: Many health-related websites provide information on the LIPA gene and lipase deficiency. These websites often include information on the symptoms, diagnosis, and treatment of lipase deficiency.

When searching for information on the LIPA gene and lipase deficiency, it is important to use the appropriate keywords such as “LIPA gene,” “lipase deficiency,” “lysosomal acid lipase deficiency,” or “cholesteryl ester storage disease.” Using these keywords will help narrow down the search results and provide relevant information.

Overall, gene and variant databases, along with other related resources, play an important role in providing researchers and healthcare professionals with access to information about the LIPA gene, lipase deficiency, and related diseases. They help in understanding the genetic changes associated with lipase deficiency and provide valuable information for diagnosis and treatment.

References

  • Article: and A, B. and C. (Year). “Title of the Article”. Journal Name, volume(issue), pages. DOI.

  • Article: and D, E. and F. (Year). “Title of the Article”. Journal Name, volume(issue), pages. DOI.

  • Article: and G, H. and I. (Year). “Title of the Article”. Journal Name, volume(issue), pages. DOI.

Additional articles and scientific resources related to the LIPA gene and lysosomal acid lipase deficiency can be found in the following databases:

  1. OMIM – Online Mendelian Inheritance in Man: https://www.omim.org/
  2. Lysosomal Acid Lipase Deficiency Registry: https://www.acylregistry.org/
  3. PubMed – Search for LIPA gene and lysosomal acid lipase deficiency: https://pubmed.ncbi.nlm.nih.gov/

These resources provide information on relevant genetic changes, disease conditions, and testing methods for the LIPA gene and lysosomal acid lipase deficiency. They list the names of other genes and mutations related to lysosomal acid lipase deficiency, as well as provide additional articles and scientific databases for further research.

Please note that the information provided in this article is for health education purposes only and should not be used as a substitute for professional medical advice. Consult a healthcare provider for diagnosis and treatment options related to lysosomal acid lipase deficiency.

Related Posts